To achieve this, 230 NSCLC patients from the TCGA database were categorized into SLIT3-high and SLIT3-low groups, and the top 20 differentially expressed genes between these groups were enriched (Figure 2a). The gene discussed is SLIT3; the disease is non-small cell lung carcinoma.